Schiano Lomoriello D, Parravano M C, Chiaravalloti A, Varano M
Fondazione G.B. Bietti-IRCCS, Roma, Italy.
Eur J Ophthalmol. 2009 Jan-Feb;19(1):151-3. doi: 10.1177/112067210901900125.
To report the efficacy of intravitreal injection of bevacizumab 1.25 mg (IVB) in the treatment of choroidal neovascularization (CNV) secondary to angioid streaks (AS).
Case review of two patients with CNV secondary to AS treated with three IVB with a 1-year follow up.
In both patients after 1 year fluorescein angiography and optical coherence tomography showed complete inactivity of the CNV and the ophthalmologic examination revealed stabilization of the visual acuity.
The IBV appeared to be an effective and safe treatment for CNV secondary to AS resulting in a long-term CNV inactivation. Further long-term studies in this type of lesion are desirable.
报告玻璃体内注射1.25毫克贝伐单抗(IVB)治疗血管样条纹(AS)继发脉络膜新生血管(CNV)的疗效。
对2例AS继发CNV患者进行病例回顾,给予3次IVB治疗,并随访1年。
1年后,两名患者的荧光素血管造影和光学相干断层扫描显示CNV完全静止,眼科检查显示视力稳定。
IVB似乎是治疗AS继发CNV的一种有效且安全的方法,可导致CNV长期静止。对此类病变进行进一步的长期研究是必要的。